Vascular calcification: Types and mechanisms;Calcificación vascular: Tipos y mecanismos

Nefrologia

Volumn 31, Issue 2, 2011, Pages 142-147

  Valdivielso, J M ^a  

^a HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

Author keywords

End stage kidney disease; Intimal calcification; Medial calcification; Vascular calcification

Indexed keywords

CALCIUM PHOSPHATE; PROTEIN;

ANIMAL; APOPTOSIS; ATHEROSCLEROTIC PLAQUE; BIOLOGICAL MODEL; CALCINOSIS; CLASSIFICATION; DIABETIC ANGIOPATHY; DISEASE PREDISPOSITION; ELASTIC TISSUE; HUMAN; INTIMA; KIDNEY DISEASE; METABOLISM; MOUSE; MOUSE MUTANT; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; REVIEW; TUNICA MEDIA; VASCULAR DISEASE;

ANIMALS; APOPTOSIS; CALCINOSIS; CALCIUM PHOSPHATES; DIABETIC ANGIOPATHIES; DISEASE SUSCEPTIBILITY; ELASTIC TISSUE; HUMANS; KIDNEY DISEASES; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; PLAQUE, ATHEROSCLEROTIC; PROTEINS; TUNICA INTIMA; TUNICA MEDIA; VASCULAR DISEASES;

EID: 79954524835     PISSN: 02116995     EISSN: None     Source Type: Journal    
DOI: 10.3265/Nefrologia.pre2010.Nov.10754     Document Type: Review

References (56)

1. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephro 2004;15:2959-64.
2. Burke AP, Taylor A, Farb A, et al. Coronary calcification: insights from sudden coronary death victims. Z Kardiol 2000;89(Suppl 2):49-53.
3. Edmonds ME, Morrison N, Laws JW, Watkins PJ. Medial arterial calcification and diabetic neuropathy. Br Med J (Clin Res Ed) 1982;284:928-30.
4. Schwarz U, Buzello M, Ritz E, et al. Morphology of coronary atherosclerotic lesions in patients with end-stage renal failure. Nephrol Dial Transplant 2000;15:218-23.
5. Ibels LS, Alfrey AC, Huffer WE, et al. Arterial calcification and pathology in uremic patients undergoing dialysis. Am J Med 1979;66:790-6.
6. McCullough PA, Chinnaiyan KM, Agrawal V, et al. Amplification of atherosclerotic calcification and Monckeberg's sclerosis: a spectrum of the same disease process. Adv Chronic Kidney Dis 2008;15:396-412.
7. Mönckeberg JG. Ueber die reine Mediaverlakalkung der Extremitaetenarterien und ihr Verhalten zur Arteriosklerose. Virchows Arch A Pathol Anat Histol 1903;171:141-67.
8. Shanahan CM, Cary NR, Salisbury JR, et al. Medial localization of mineralization-regulating proteins in association with Monckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification. Circulation 1999;100:2168-76.
9. Schoppet M, Al Fakhri N, Franke FE, et al. Localization of osteopro-tegerin, tumor necrosis factor-related apoptosis-inducing ligand, and receptor activator of nuclear factor-kappa B ligand in Monckeberg's sclerosis and atherosclerosis. J Clin Endocrinol Metab 2004;89:4104-12.
10. Castillo BV, Jr., Torczynski E, Edward DP. Monckeberg's sclerosis in temporal artery biopsy specimens. Br J Ophthalmol 1999;83:1091-2.
11. Micheletti RG, Fishbein GA, Currier JS, et al. Calcification of the internal elastic lamina of coronary arteries. Mod Patho 2008;21:1019-28.
12. Goebel FD, Fuessl HS. Monckeberg's sclerosis after sympathetic denervation in diabetic and non-diabetic subjects. Diabetologia 1983;24:347-50.
13. Coll B, Betriu A, Martínez-Alonso M, et al. Large Artery Calcification on Dialysis Patients Is Located in the Intima and Related to Atherosclerosis. Clin J Am Soc Nephrol 2010. En prensa doi:10.2215/CJN.04290510.
14. Speer MY, Giachelli CM. Regulation of cardiovascular calcification. Cardiovascular Pathology 2004;13:63-70.
15. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: A national study. Am J Kidney Dis 1998;31:607-17.
16. Block GA, Port FK. Re-evaluation of risks associated with hyperphosphatemia and hyperparathyroidism in dialysis patients: Recommendations for a change in management. Am J Kidney Dis 2000;35:1226-37.
17. Reynolds JL, Joannides AJ, Skepper JN, et al. Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations A potential mechanism for accelerated vascular calcification in ESRD. J Am Soc Nephrol 2004;15:2857-67.
18. Steitz SA, Speer MY, Curinga G, et al. Smooth muscle cell phenoty-pic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89:1147-54.
19. Proudfoot D, Skepper JN, Hegyi L, et al. Apoptosis regulates human vascular calcification in vitro - Evidence for initiation of vascular calcification by apoptotic bodies. Circ Res 2000;87:1055-62.
20. Tyson KL, Reynolds JL, McNair R, et al. Osteo/chondrocytic transcription factors and their target genes exhibit distinct patterns of expression in human arterial calcification. Arterioscler Thromb Vasc Biol 2003;23:489-94.
21. Mori K, Shioi A, Jono S, et al. Expression of matrix Gla protein (MGP) in an in vitro model of vascular calcification. FEBS Lett 1998;433:19-22.
22. Jono S, Ikari Y Vermeer C, et al. Matrix Gla protein is associated with coronary artery calcification as assessed by electron-beam computed tomography. Thromb Haemost 2004;91:790-4.
23. Luo G, Ducy P, Mckee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature 1997;386:78-81.
24. Heiss A, DuChesne A, Denecke B, et al. Structural basis of calcification inhibition by alpha 2-HS glycoprotein/fetuin-A. Formation of coloidal calciprotein particles. J Biol Chem 2003;278:13333-41.
25. Schafer C, Heiss A, Schwarz A, et al. The serum protein alpha 2-He-remans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification. J Clin Invest 2003;112:357-66.
26. Giachelli CM, Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000;19:615-22.
27. Ikeda T, Shirasawa T, Esaki Y, et al. Osteopontin mRNA is expressed by smooth muscle-derived foam cells in human atherosclerotic lesions of the aorta. J Clin Invest 1993;92:2814-20.
28. Fitzpatrick LA, Severson A, Edwards WD, Ingram RT. Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest 1994;94:1597-604.
29. Hirota S, Imakita M, Kohri K, et al. Expression of osteopontin messenger RNA by macrophages in atherosclerotic plaques. A possible association with calcification. Am J Pathol 1993;143:1003-8.
30. Speer MY, Mckee MD, Guldberg RE, et al. Inactivation of the osteopontin gene enhances vascular calcification of matrix Gla protein-deficient mice: evidence for osteopontin as an inducible inhibitor of vascular calcification in vivo. J Exp Med 2002;196:1047-55.
31. Simonet WS, Lacey DL, Dunstan CR, et al. Osteoprotegerin: A nove secreted protein involved in the regulation of bone density. Cell 1997;89:309-19.
32. Collin-Osdoby P. Regulation of vascular calcification by osteoclast regulatory factors RANKL and osteoprotegerin. Circ Res 2004;95:1046-57.
33. Bucay N, Sarosi I, Dunstan CR, et al. osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes & Development 1998;12:1260-8.
34. Jono S, Ikari Y Shioi A, et al. Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation 2002;106:1192-4.
35. Moe SM, Duan D, Doehle BP, et al. Uremia induces the osteoblast differentiation factor Cbfa1 in human blood vessels. Kidney Int 2003;63:1003-11.
36. Tintut Y Patel J, Parhami F, Demer LL. Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation 2000;102:2636-42.
37. Stenvinkel P, Ketteler M, Johnson RJ, et al. IL-10, IL-6, and TNF-al-pha: central factors in the altered cytokine network of uremia-the good, the bad, and the ugly. Kidney Int 2005;67:1216-33.
38. Watson KE, Parhami F, Shin V, Demer LL. Fibronectin and collagen I matrixes promote calcification of vascular cells in vitro, whereas collagen IV matrix is inhibitory. Arterioscler Thromb Vasc Biol 1998;18:1964-71.
39. Watson KE, Bostrom K, Ravindranath R, et al. TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest 1994;93:2106-13.
40. Shioi A, Katagi M, Okuno Y et al. Induction of bone-type alkaline phosphatase in human vascular smooth muscle cells: roles of tumor necrosis factor-alpha and oncostatin M derived from macrophages. Circ Res 2002;91:9-16.
41. Jono S, Nishizawa Y Shioi A, Morii H. 1,25-dihydroxyvitamin D-3 increases in vitro vascular calcification by modulating secretion of endogenous parathyroid hormone-related peptide. Circulation 1998;98:1302-6.
42. Ducy P Zhang R, Geoffroy V, et al. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell 1997;89:747-54.
43. Jono S, Mckee MD, Murry CE, et al. Phosphate regulation of vascular smooth muscle cell calcification. Circ Res 2000;87:E10-E17.
44. Chen D, Zhao M, Mundy GR. Bone morphogenetic proteins. Growth Factors 2004;22:233-41.
45. Wang EA, Rosen V, D'Alessandro JS, et al. Recombinant human bone morphogenetic protein induces bone formation. Proc Natl Acad Sci USA 1990;87:2220-4.
46. Hruska KA, Mathew S, Saab G. Bone morphogenetic proteins in vascular calcification. Circ Res 2005;97:105-14.
47. Bostrom K, Watson KE, Horn S, et al. Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest 1993;91:1800-9.
48. Shin V, Zebboudj AF, Bostrom K. Endothelial cells modulate osteogenesis in calcifying vascular cells. J Vasc Res 2004;41:193-201.
49. Zebboudj AF, Imura M, Bostrom K. Matrix GLA protein, a regulatory protein for bone morphogenetic protein-2. J Biol Chem 2002;277:4388-94.
50. Kong YY, Boyle WJ, Penninger JM. Osteoprotegerin ligand: a regulator of immune responses and bone physiology. Immunol Today 2000;21:495-502.
51. Kong YY, Feige U, Sarosi I, et al. Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin igand. Nature 1999;402:304-9.
52. Anderson DM, Maraskovsky E, Billingsley WL, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-9.
53. Myers DE, Collier FM, Minkin C, et al. Expression of functiona RANK on mature rat and human osteoclasts. FEBS Lett 1999;463:295-300.
54. Green EA, Flavell RA. TRANCE-RANK, a new signal pathway involved in lymphocyte development and T cell activation. J Exp Med 1999;189:1017-20.
55. Kanegae Y, Tavares AT, Izpisua Belmonte JC, Verma IM. Role of Rel/NF-kappaB transcription factors during the outgrowth of the vertebrate limb. Nature 1998;392:611-4.
56. Yasuda H, Shima N, Nakagawa N, et al. Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 1998;95:3597-602.